EP Wealth Advisors LLC Invests $138,000 in Tactile Systems Technology, Inc. $TCMD

EP Wealth Advisors LLC acquired a new position in Tactile Systems Technology, Inc. (NASDAQ:TCMD) during the first quarter, according to its most recent 13F filing with the SEC. The firm acquired 10,436 shares of the company’s stock, valued at approximately $138,000.

A number of other large investors also recently modified their holdings of the company. Trexquant Investment LP purchased a new position in shares of Tactile Systems Technology in the 1st quarter worth about $232,000. Virtus Advisers LLC acquired a new stake in shares of Tactile Systems Technology in the first quarter valued at about $198,000. AlphaQuest LLC grew its stake in shares of Tactile Systems Technology by 171.3% in the first quarter. AlphaQuest LLC now owns 25,084 shares of the company’s stock valued at $332,000 after buying an additional 15,837 shares in the last quarter. Martingale Asset Management L P grew its stake in shares of Tactile Systems Technology by 49.2% in the first quarter. Martingale Asset Management L P now owns 76,723 shares of the company’s stock valued at $1,014,000 after buying an additional 25,311 shares in the last quarter. Finally, Algert Global LLC acquired a new stake in shares of Tactile Systems Technology in the first quarter valued at about $160,000. 83.43% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Tactile Systems Technology

In other news, CEO Sheri Louise Dodd sold 7,762 shares of Tactile Systems Technology stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $12.36, for a total value of $95,938.32. Following the completion of the transaction, the chief executive officer owned 173,479 shares in the company, valued at approximately $2,144,200.44. This trade represents a 4.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on TCMD. William Blair upgraded Tactile Systems Technology to a “strong-buy” rating in a research note on Tuesday, August 5th. B. Riley reiterated a “neutral” rating and issued a $13.00 target price (up previously from $12.00) on shares of Tactile Systems Technology in a research note on Tuesday, August 5th. Finally, Wall Street Zen upgraded Tactile Systems Technology from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. One investment analyst has rated the stock with a Strong Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $13.50.

Tactile Systems Technology Price Performance

Shares of TCMD opened at $13.26 on Thursday. The firm has a market cap of $295.57 million, a price-to-earnings ratio of 21.39 and a beta of 1.04. The stock has a 50 day moving average of $11.60 and a 200-day moving average of $11.91. The company has a current ratio of 3.79, a quick ratio of 3.36 and a debt-to-equity ratio of 0.11. Tactile Systems Technology, Inc. has a 52 week low of $8.61 and a 52 week high of $21.10.

Tactile Systems Technology (NASDAQ:TCMD) last issued its earnings results on Monday, August 4th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. The company had revenue of $78.91 million during the quarter, compared to analyst estimates of $73.93 million. Tactile Systems Technology had a return on equity of 7.72% and a net margin of 5.06%. Tactile Systems Technology has set its FY 2025 guidance at EPS. As a group, analysts forecast that Tactile Systems Technology, Inc. will post 0.7 EPS for the current year.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.